Podcasts about pfms

Step into Dental Unscripted replacing Acquisition Unscripted.Hosts Michael Dinsio and Paula Quinn, alongside industry experts like executive coach Michael Clark with Next Level Consultants. Our NEW CHANNEL breaks down the dental practice ownership journey with raw, real, and actionable insights. From startups to acquisitions to running a successful practice, this podcast covers it all, one unfiltered episode at a time. In this installment, aired March 27, 2025, the trio dives deep into patient financing—a game changer for boosting case acceptance and turning unscheduled treatment into revenue.Why does patient financing matter? Michael Clark, a former CareCredit insider, reveals that 15-20% of patients walk in unprepared to pay, leaving practices with massive unscheduled treatment lists (think $1.2-$1.5 million for a $1 million practice). The team unpacks stats showing 50% of revenue comes from insurance, 35% from traditional payments like Visa or cash, and the critical gap financing fills. They tackle why practices shy away—staff discomfort with money talks, misconceptions about fees (it's a merchant fee, not interest!), and “legacy office managers” pushing risky in-house payment plans that rarely get collected past 120 days. Paula shares her own experience as a practice owner and how she picked and chose when to use financing options, while Mike highlights a $1.6 million practice only offered patient financing just once - in an entire year. The conversation gets practical: offer financing on 100% of treatment plans, lead with multiple options (cash discounts, credit cards, third-party lenders like CareCredit, Covered Care, or Clarity Pay), and let patients choose. Why? Because 25-30% of those who leave without scheduling get treatment elsewhere, and same-day acceptance is dropping. From clear aligners to high-end restorations, financing can elevate care levels—like zirconia crowns over PFMs or premium dentures over basics. Plus, hear a story of a patient swayed by low monthly payments, proving presentation is everything.Now unified under the Dental Unscripted banner (bye-bye Startup Unscripted and Acquisition Unscripted), this navy blue and turquoise-branded show—complete with a big tooth logo—is your go-to for practice management gold. https://dental-unscripted.transistor.fm/0:00 Intro4:26 Why Use Patient Financing7:46 Statistics, and Opportunities in Your Practice13:20 Case Acceptance Rate, Verbal Skills, & Options14:47 Why Offices Are Using Patient Financing20:47 Why patients NEED Financing 25:01 Increase Patient Care Option27:38 Which Financing Companies to Use?Sponsored by Candid Pro, a clear aligner system built for general dentists to drive efficiency and profit, this episode offers a special deal https://candidpro.com/nxlevel. Get an amazing deal and exclusive offer via this link. Subscribe on Apple, Spotify, or YouTube, Rate us, and follow for more. Need help with case acceptance or setting up shop? The team's got you covered. Visit https://nxlevelconsultants.com to find out more on how Michael Dinsio & Paula Quinn can help you with your career as a dentists! 

O Open Finance tem sido um dos maiores motores de transformação no mercado financeiro, possibilitando novos modelos de negócio, experiências mais integradas e um maior grau de personalização para os consumidores. Mas até onde essa infraestrutura pode chegar? Como ela está impactando empresas e usuários na prática?Neste episódio do Fintech Talks, recebemos a Ingrid Barth, CEO do PilotIn, para discutir como as instituições estão explorando esse novo cenário e quais as oportunidades mais promissoras que estão surgindo. Além de abordarmos a trajetória profissional da Ingrid e o desenvolvimento do PilotIn, falamos sobre a evolução dos gerenciadores financeiros pessoais (PFMs), a criação de novas interfaces para o relacionamento com as finanças e o impacto do Open Finance na competição entre instituições financeiras e novos entrantes.Além disso, exploramos os desafios da adoção dessa tecnologia, o futuro dos superapps financeiros, a crescente interseção entre o mercado financeiro e outros setores e como players inovadores estão ajudando a transformar a experiência dos usuários!Confira!

Dr. Pol Boudes, CMO of Rectify Pharmaceutical, highlights the importance of membrane proteins, specifically the role transporters play in how cells interact with their environment. Rectify is working on developing positive functional modulators (PFM) to address diseases related to dysfunctional transporters the first being primary sclerosing cholangitis, a rare liver disease with no current treatment options. The PFM can potentially restore the normal function of transporters involved in bile composition and secretion, which are key mechanisms in PSC.   Pol explains, "So you have different types of membrane proteins, but what we're working with are called transporters, so they're proteins that are based on the membrane but channel components out and in the cells. So basically, it's a way for the cell to interact with its environment, and you have multiple types of transporter proteins. We're specifically working or started to work with one group of family of proteins that are called the ABC transporters. They're a very important function, and they can either be disrupted because there is a mutation in the protein, so it's a genetic disease, or they are potentially disrupted because there is just a functional deficit of this transporter. The protein is normal, but it's not functioning properly. So it's a functional deficit of what we call the wildtype protein." "So with the PFMs, what we're doing is to use small molecules that you can administer orally, and they bind to the transporter, and by doing so, they can modify the three-dimensional structure of the transporter and consequently the way this protein behaves within the cellular environment. So we correct the function of the transporter by changing the size, if you want, of the shape of the transporter. So we started to focus on this type of proteins and you have many potential diseases due to transporter deficit."  "We're focusing on one disease, liver disease. That's our lead PFM for a disease called primary sclerosing cholangitis, which is a disease of the liver. This very severe liver disease is also a disease that has no treatment available, which is a little bit frustrating because the progression of this disease leads to liver cirrhosis. And the only thing you can do at this stage is liver transplantation. As you might know, liver transplantation is problematic because it's a very complex process, it's also very expensive, and unfortunately, there is a shortage of transplants. So we're trying to address this problem." #RectifyPharma #PrimarySclerosingCholangitis #PSC #RareDisease #LiverDiseases #BileProduction #Transporters rectifypharma.com Download the transcript here

Dr. Pol Boudes, CMO of Rectify Pharmaceutical, highlights the importance of membrane proteins, specifically the role transporters play in how cells interact with their environment. Rectify is working on developing positive functional modulators (PFM) to address diseases related to dysfunctional transporters the first being primary sclerosing cholangitis, a rare liver disease with no current treatment options. The PFM can potentially restore the normal function of transporters involved in bile composition and secretion, which are key mechanisms in PSC.   Pol explains, "So you have different types of membrane proteins, but what we're working with are called transporters, so they're proteins that are based on the membrane but channel components out and in the cells. So basically, it's a way for the cell to interact with its environment, and you have multiple types of transporter proteins. We're specifically working or started to work with one group of family of proteins that are called the ABC transporters. They're a very important function, and they can either be disrupted because there is a mutation in the protein, so it's a genetic disease, or they are potentially disrupted because there is just a functional deficit of this transporter. The protein is normal, but it's not functioning properly. So it's a functional deficit of what we call the wildtype protein." "So with the PFMs, what we're doing is to use small molecules that you can administer orally, and they bind to the transporter, and by doing so, they can modify the three-dimensional structure of the transporter and consequently the way this protein behaves within the cellular environment. So we correct the function of the transporter by changing the size, if you want, of the shape of the transporter. So we started to focus on this type of proteins and you have many potential diseases due to transporter deficit."  "We're focusing on one disease, liver disease. That's our lead PFM for a disease called primary sclerosing cholangitis, which is a disease of the liver. This very severe liver disease is also a disease that has no treatment available, which is a little bit frustrating because the progression of this disease leads to liver cirrhosis. And the only thing you can do at this stage is liver transplantation. As you might know, liver transplantation is problematic because it's a very complex process, it's also very expensive, and unfortunately, there is a shortage of transplants. So we're trying to address this problem." #RectifyPharma #PrimarySclerosingCholangitis #PSC #RareDisease #LiverDiseases #BileProduction #Transporters rectifypharma.com Listen to the podcast here

The last several years have seen quite the rollercoaster of investment-related trends: meme stonks, SPACs, crypto, and now… Treasuries? Another emerging trend: generative AI. In this episode, I had the chance to sit down with investing app Public's co-CEO Leif Abraham to talk about all of that and more, including:* How AI for investing is and isn't different than previous trends like PFMs and roboadvisors* How Public got comfortable deploying user-facing AI capabilities* Why Public ended payment for order flow (PFOF) and decided to accept “tips”* How Public stands out in a crowded investing market* and more!Also, a big congrats to the Public team on today's announcement of their expansion to the UK market!Existing subscriber? Please consider supporting this newsletter by upgrading to a paid subscription. New here? Subscribe to get Fintech Business Weekly each Sunday: Get full access to Fintech Business Weekly at fintechbusinessweekly.substack.com/subscribe

The public launch of generative AI in the form of ChatGPT greased the creative wheels for the impact of these types of technology. We're seeing experts and firms scurrying, just trying to wrap their minds and their hands around AI.  We had something similar a few years ago when chatbots for financial services started getting interesting. The thing is – these were primarily black-box technologies that seemed very abstract from daily life for consumers and for the teams of developers at banks tasked with managing them. ChatGPT changed that and with a slight change in interface, it's unlocked a lot of use cases for financial services. We're early for sure in this evolution but companies that have been studying the space are already beginning to make a move. ApexEdge provides consumers – through their banks and fintechs – subscription management tools. Want to easily unsubscribe from a subscription to a streaming service you're not using much? ApexEdge makes that easy. It even has created technology to help you negotiate how much you're paying for your subscription services. The firm, which has been curiously studying the evolution of generative AI since ChatGPT-1, is already at work building the next generation of its product with ChatGPT at its center – including embedding it into how its flagship product works, as well as implementing AI tools internally to boost efficiency and increase productivity.  For ApexEdge, it's a lot about scaling efficiently.  This is one of the first cases we've seen of a fintech firm embracing the next generation of AI tools so openly.  This story is part of a collaboration between ApexEdge and Tearsheet Studios. To read more, please head over to Tearsheet where there's a downloadable guide and two episodes of a podcast about how ApexEdge is using AI as a foundation for the next generation of its product, as well as an important resource inside the firm.  Michel Mora is the CTO of ApexEdge, which runs Billshark, a popular consumer app that enables people to easily cancel subscription payments they're making to streaming services, for example. ApexEdge utilizes the same technology to enable banks, FIs, and PFMs to offer similar services to their customers. Download a guide to how ApexEdge is using ChatGPT to power the next generation of its product and workforce here: www.library.tearsheet.co/apexedge23

The public launch of generative AI in the form of ChatGPT greased the creative wheels for the impact of these types of technology. We're seeing experts and firms scurrying, just trying to wrap their minds and their hands around AI.  We had something similar a few years ago when chatbots for financial services started getting interesting. The thing is – these were primarily black-box technologies that seemed very abstract from daily life for consumers and for the teams of developers at banks tasked with managing them. ChatGPT changed that and with a slight change in interface, it's unlocked a lot of use cases for financial services. We're early for sure in this evolution but companies that have been studying the space are already beginning to make a move. ApexEdge provides consumers – through their banks and fintechs – subscription management tools. Want to easily unsubscribe from a subscription to a streaming service you're not using much? ApexEdge makes that easy. It even has created technology to help you negotiate how much you're paying for your subscription services. The firm, which has been curiously studying the evolution of generative AI since ChatGPT-1, is already at work building the next generation of its product with ChatGPT at its center – including embedding it into how its flagship product works, as well as implementing AI tools internally to boost efficiency and increase productivity.  For ApexEdge, it's a lot about scaling efficiently.  This is one of the first cases we've seen of a fintech firm embracing the next generation of AI tools so openly.  This story is part of a collaboration between ApexEdge and Tearsheet Studios. To read more, please head over to Tearsheet where there's a downloadable guide and two episodes of a podcast about how ApexEdge is using AI as a foundation for the next generation of its product, as well as an important resource inside the firm.  Steve McKean is the CEO of ApexEdge, which runs Billshark, a popular consumer app that enables people to easily cancel subscription payments they're making to streaming services, for example. ApexEdge utilizes the same technology to enable banks, FIs, and PFMs to offer similar services to their customers. Download a guide to how ApexEdge is using ChatGPT to power the next generation of its product and workforce here: https://www.library.tearsheet.co/apexedge23

Gaël Musquet est un hacker citoyen, un fervent ambassadeur des logiciels libres et open source notamment OpenStreetMap. Il met les technologies au service de la prévention des risques naturels et pour une meilleure résilience face aux chocs. Les sujets abordés : * Qu'est ce qu'être « hacker citoyen » ? * L'utilisation des technologies au service de la prévention des désastres naturels * Déclic concernant le changement climatique dû aux activités humaines ? * Comment les Antilles se préparent aux effets du dérèglement climatique ? * Comment expliquer la défiance vis à vis du vaccin ? * Déploiement de la 5G * Comment envisager l'avenir : tout technologique ou low tech ? En savoir plus * Le Plan Familial de Mise en Sûreté (PFMS) https://www.risques-majeurs.info/fiche/plaquette-je-me-prot-ge-en-famille-le-plan-familial-de-mise-en-s-ret-pfms * Le Document d'Information Communal sur les Risques Majeurs (DICRIM) https://www.risques-inondations.fr/les-dicrim * La convention de Sendai https://www.un.org/press/fr/2015/iha1361.doc.htm * Caribe wave https://www.tsunamizone.org/francais/caribewave/ * Ouragan Hugo (1989) https://la1ere.francetvinfo.fr/guadeloupe/il-y-29-ans-cyclone-hugo-ravageait-guadeloupe-628244.html

Go to the website for Otomo and here's what jumps out at you: "Be the money platform people love. Turn any account holder into an avid user with autonomous personal money management."Read it again.What Otomo is about is a revolution in our digital money management and here is a fact: on a fundamental level, online and mobile banking are not substantially different from what debuted in the mid 1990s.  Another fact: PFMs are not significantly more engaging than they were when they were introduced a generation ago.Otomo's plan is to revolutionize all of that.To rethink how we bank.And, yes, to make it all much more engaging - and fun! - than we are accustomed to.On its LinkedIn page, Otomo says about itself: "Picture a world where your money knows where to go as soon as it hits your bank account, organizing itself in real-time. Sounds like something out of Blade Runner? It's not. "Otomo is delivering on banking's ultimate promise of hyper-personalized cash management tools today. We deliver our service directly through your favorite financial institution or money app. In other words, you'll quickly be able to offer smart banking that can provide engaging, long-lasting, and meaningful experiences to your customers."Ready to hear more about the Otomo revolution? In this podcast you will hear at length from Khellar Crawford, CEO and co-founder of Otomo and you will also hear why he founded it and why your credit union just may wat to explore deploying it to your members.Face it? Members increasingly want more from their digital banking experience than they are getting.  Otomo just may be what they are hunting.Listen up.Like what you are hearing? Find out how you can help sponsor this podcast here. Very affordable sponsorship packages are available. Email rjmcgarvey@gmail.comAnd like this podcast on whatever service you use to stream it. That matters.Find out more about CU2.0 and the digital transformation of credit unions here. It's a journey every credit union needs to take. Pronto

Donate to the Race For the Future 7.0! Aug 28-29 in Chicago, Ill. (http://dentallabfoundation.org/news-events/race-for-the-future/) If you have ever been to a dental show like LMT Lab Day Chicago or Vision 21, you probably have seen a guy with white hair and a white beard with a thick southern accent making a group of people laugh. That is Harold Burdette from "Lab of the Year" Burdette Dental Laboratory (https://www.burdettedental.com/). Harold comes on the podcast to talk about working in his dad's lab back in the 70s (starting during the beginning of PFMs) and growing that business to become one of the longest family owned labs, being a part of the TEREC group (http://terecna.com/), and what a semi-retired technician does when he hands to lab to the next generation in his family. Great stories from a technician that knows it all. Whip Mix (https://www.whipmix.com/) introduces the CUREbox Plus (https://www.whipmix.com/products/curebox-plus/), a new curing unit that ensures the proper and full polymerization of 3D printed resins. It really is the ideal curing unit for dental labs and dentists because the CUREbox Plus uses light and heat energy, with controlled time and temperature, to provide an ideal environment suitable for post-curing SLA and DLP type 3D printed models. The American-made, competitively priced curing unit is very easy to use and has a large capacity curing chamber for high production, is super easy to clean and maintain, and offers a one-year warranty which covers everything but the inexpensive, long-lasting UV LED lamps. Though the CUREbox Plus can cure virtually any printed resin, it has been qualified with the following Whip Mix resins: Veriguide OS (https://www.whipmix.com/products/veriguide-os-clear/), VeriSplint OS (https://www.whipmix.com/products/verisplint-os-3d-print-resin/), Dentca denture base (https://www.whipmix.com/products/dentca/), denture teeth, try-in, and Temporary Crown and Bridge (https://www.whipmix.com/products/dentca-temporary-crown-bridge-resin/). If you'd like to learn more about this in-demand product, visit www.whipmix.com. Special Guest: Harold Burdette.

In this episode of The Challengers, Josh Liggett and Zack Miller explore the pandemic's impact on incumbent banks as well as on challengers. Zack mentioned fears are high and that's creating rumors that certain challengers are failing. Josh believes it's a good time for incumbents to really get focused around digital. They have no other choice. Next, the hosts discuss OakNorth, which is still Europe's fastest growing startup. But growth of its loan book is slowing, whether by design or by market forces. The bank is profitable -- perhaps the only one of many challengers to reach this milestone. Square gets a license and Zack believes that we'll see Square move strongly into lending to merchants using its technology. Like PayPal, Amazon, and Shopify, this captured lending is powerful and makes a ton of sense from a service model perspective. It can also be quite lucrative. Credit Sesame, like Credit Karma a few months before it, is rolling out a banking product, Sesame Cash. PFMs want to own the money movement piece for their customers. Lastly, we mention Bill Harris' new firm, One, which just launched in private beta after a $17 million funding round. Harris was CEO at PayPal and Intuit, and founded Personal Capital before this. In perhaps the worst launch timing in history, One will use dashboards with consumer credit at its core to help middle Americans with their money. Before we jump into the podcast, I wanted to introduce you to Outlier, Tearsheet’s leading membership program. It’s designed for top fintech and financial service professionals to stay on top daily of the biggest trends, the top companies, and the leaders of this next generation of finance. Get industry briefings by experts like the ones we’re doing this January on best practices in PR and customer acquisition. Find out more at Tearsheet.co/outlier

Our Dental-Up Podcast guest this week is Dr. John Kanca,  joining our guest host Bob Brandon as they discuss Dr. Kanca's process in creating the latest product addition to Apex Dental Materials, ZR-P Primer. Dr. Kanca explains the testing process and the positive results when prescribing the KDZ Bruxer® and KDZ Bruxer Aesthetic®.  He explains why it's important to use a high quality light source when working with zirconia materials. You will also learn Dr. Kanca's clinical protocol for cementation with the Apex Dental Materials line-up, including PFMs and lithium discilicate, and PFM restorations.  You will hear all this and more on this week's episode of the Dental Up Podcast. In this Episode you will hear about:-Dr.Kanca explains his rationale for prescribing KDZ Bruxer Aesthetic -Dr. Kanca's testing process of ZR-P on the KDZ Bruxer - Why having 2mm occlusal reduction in the central fossa helps the lab create functional anatomy without complications. - Dr. Kanca's clinical protocol for cementation using the Apex Dental Material line of products on zirconia, PFM, and lithium discilicate restorations. -The Importance of utilizing a high quality light source when working with zirconia materials. For more information on Dr. Kanca's practice or for more information on The Apex Dental Materials, check the links down below. Practice Website: http://middleburysmiles.com Apex Dental Website: https://apexdentalmaterials.com Upcoming Events: https://www.gnydm.com/educationce/speakers/ 

Our Dental-Up Podcast guest this week is Dr. John Kanca,  joining our guest host Bob Brandon as they discuss Dr. Kanca’s process in creating the latest product addition to Apex Dental Materials, ZR-P Primer. Dr. Kanca explains the testing process and the positive results when prescribing the KDZ Bruxer® and KDZ Bruxer Aesthetic®.  He explains why it’s important to use a high quality light source when working with zirconia materials. You will also learn Dr. Kanca’s clinical protocol for cementation with the Apex Dental Materials line-up, including PFMs and lithium discilicate, and PFM restorations.  You will hear all this and more on this week’s episode of the Dental Up Podcast. In this Episode you will hear about:-Dr.Kanca explains his rationale for prescribing KDZ Bruxer Aesthetic -Dr. Kanca’s testing process of ZR-P on the KDZ Bruxer - Why having 2mm occlusal reduction in the central fossa helps the lab create functional anatomy without complications. - Dr. Kanca’s clinical protocol for cementation using the Apex Dental Material line of products on zirconia, PFM, and lithium discilicate restorations. -The Importance of utilizing a high quality light source when working with zirconia materials. For more information on Dr. Kanca’s practice or for more information on The Apex Dental Materials, check the links down below. Practice Website: http://middleburysmiles.com Apex Dental Website: https://apexdentalmaterials.com Upcoming Events: https://www.gnydm.com/educationce/speakers/ 

Welcome to the Tearsheet Podcast. I’m Zack Miller. We’ve been covering the data aggregation industry because it’s our contention that getting this right is one of the underpinnings of modern finance. Sharing clean data between banks and apps may be somewhat of a boring business but it’s an important one. Plaid recently launched Liabilities, a product that gives PFMs and student loan providers and refinancers access to the liabilities side of their potential clients’ balance sheets. This is a very active area of fintech and this should help to propel things forward. Plaid’s Lowell Putnam joins us on the podcast to talk about the new product and how clients are using it in their applications. Lowell was also the founder of Quovo, a data agg competitor with strength in the investment industry, that Plaid acquired earlier in 2019. He talks about the combined entity and provides some insight into the product roadmap the company plans to execute on. Lowell Putnam is my guest on the Tearsheet Podcast. We’d like to thank our sponsor MX for supporting Tearsheet’s work. MX is the leading data platform for banks, credit unions and fintechs, enabling its clients and partners to easily collect, enhance, analyze, present and act on financial data.

On this week's episode of The Dental-Up Podcast, we have Bob Brandon as our special guest host.  Bob sat down with his father, Dr. Dale Brandon and discussed his illustrious 50 Years in clinical practice. They talked about the evolution of the dental profession over the past half-century, and discussed dental materials, preparation designs, restorative processes, and his own experience with Keating Dental Arts products. Talking points in this episode:  -Axial wall and occlusal reduction -Why Dr. Brandon made the switch from PFMs to KDZ Bruxer™ crowns. -His personal experience with the KDZ Bruxer Aesthetic™ crowns and e.max veneers. -Smile line evaluation, and how to determine where to place the maxillary incisal edge. -Dr. Brandon's experience with the Keating Custom Abutments.

On this week’s episode of The Dental-Up Podcast, we have Bob Brandon as our special guest host.  Bob sat down with his father, Dr. Dale Brandon and discussed his illustrious 50 Years in clinical practice. They talked about the evolution of the dental profession over the past half-century, and discussed dental materials, preparation designs, restorative processes, and his own experience with Keating Dental Arts products. Talking points in this episode:  -Axial wall and occlusal reduction -Why Dr. Brandon made the switch from PFMs to KDZ Bruxer™ crowns. -His personal experience with the KDZ Bruxer Aesthetic™ crowns and e.max veneers. -Smile line evaluation, and how to determine where to place the maxillary incisal edge. -Dr. Brandon’s experience with the Keating Custom Abutments.

In this episode of Chairside Live, watch as Dr. Muresan removes failing PFMs, and restores teeth #7-#10 with crowns and a veneer. With minimal preparation requirements, impressive strength and lifelike esthetics, Dr. Muresan selects BruxZir® Anterior for this case. She also demonstrates the use of a bone-sounding gauge instrument for esthetic analysis and a soft-tissue laser to aid in creating a beautiful new smile.

In this episode, Dr. Chi is discussing an innovation in ceramo-metal restorations that is outperforming traditional PFMs.

In this episode of Chairside Live, Dr. Anamaria Muresan replaces failing PFMs with BruxZir® Anterior crowns and veneers, and explores the advantages of BioTemps® CAD Provisionals.

In this episode of Chairside Live, Dr. Anamaria Muresan replaces failing PFMs with BruxZir® Anterior crowns and veneers, and explores the advantages of BioTemps® CAD Provisionals.

In this episode of Chairside Live, watch as Dr. Chi discusses an entirely digital treatment plan for replacing existing PFMs on tooth #18 and #19. Then, Dr. Abai answers some questions from a viewer!

In this presentation you will be introduced to a relatively new material called IPS e.max CAD. Unlike traditional PFM or zirconia-based restorations, IPS e.max CAD is milled from a single block that maintains a consistent shade throughout. With this material, there is no need to opaque out the dark metal substructure found in PFMs or keep the bright white zirconia substructure from bleeding through the ceramic. This presentation discusses the IPS e.max process used by the laboratory. It also features eight clinical cases showing how IPS e.max may be used for a variety of clinical needs.